BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7263095)

  • 1. Interaction of stannous ion with pyrrolidino-methyl tetracycline (PMT) in the preparation of PMT-99mTc radiopharmaceuticals.
    Zmbova B; Zivanov-Stakić D; Tadzer I
    Int J Appl Radiat Isot; 1981 Jul; 32(7):459-63. PubMed ID: 7263095
    [No Abstract]   [Full Text] [Related]  

  • 2. Tin-absorbed resin for the preparation of 99mTc-radiopharmaceuticals: stable complex of 99mTc-bleomycin.
    Horiuchi K; Yokoyama A; Fujibayashi Y; Tanaka H; Odori T; Saji J; Morita R; Torizuka K
    Int J Appl Radiat Isot; 1981 Jan; 32(1):47-52. PubMed ID: 6162804
    [No Abstract]   [Full Text] [Related]  

  • 3. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reaction of stannous ion with thiomalic acid in the preparation of 99mTc--thiomalate as a radiopharmaceutical.
    Ikeda I; Sakaguchi T
    Int J Appl Radiat Isot; 1977 Apr; 28(4):387-93. PubMed ID: 863534
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR; Lyster DM; Dolphin DH
    J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin.
    Yokoyama A; Terauchi Y; Horiuchi K; Okumura S; Saito Y; Tanaka H; Odori T; Morita R; Mori T; Torizuka K
    Int J Appl Radiat Isot; 1978 Oct; 29(9-10):549-55. PubMed ID: 85607
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved protein labeling by stannous tartrate reduction of pertechnetate.
    Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
    J Nucl Med; 1980 Jan; 21(1):59-62. PubMed ID: 7356741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A modified method for labeling erythrocytes with 99mTc (author's transl)].
    Kleinert P; Endert G; Klose E; Schumann E
    Rofo; 1976 Oct; 125(4):362-5. PubMed ID: 136403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
    Billinghurst MW; Waddell TL
    Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labeling of human lymphocytes with 99mTc by means of stannous pyrophosphate. Scintigraphic applications.
    Doly M; Chassagne J; Demeocq F; Finat-Duclos F; Doly A; Plagne R; Veyre A; Besse G; Gaillard G; Meyniel G
    Eur J Nucl Med; 1982; 7(9):397-404. PubMed ID: 7128628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of experimental conditions on the preparation of 99mTc-pyrrolidino-methyl tetracycline [99mTc-PMT] in the form of an instant kit.
    Shafiq YF; al-Hissoni MH; Jassim MH
    Nuklearmedizin; 1988 Aug; 27(4):154-6. PubMed ID: 3186465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The labeling of proteins and LDL with 99mTc: a new direct method employing KBH4 and stannous chloride.
    Pauwels EK; Welling MM; Feitsma RI; Atsma DE; Nieuwenhuizen W
    Nucl Med Biol; 1993 Oct; 20(7):825-33. PubMed ID: 8241994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
    Zhang ZM; Ballinger JR; Sheldon K; Boxen I
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on in vivo erythrocyte labeling with 99m Tc using stannous chloride].
    Hiraki T; Katayama M; Ando I; Ando A; Hisada K
    Kaku Igaku; 1982 Apr; 19(3):399-408. PubMed ID: 6290721
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the phytic acid effect on the labeling of blood elements with technetium-99m and on the survival of a strain of Escherichia coli treated with stannous fluoride.
    Lima-Filho GL; Lima GM; Freitas RS; Aleixo LC; Moreno SR; Catanho MT; Bernardo-Filho M
    Mol Cell Biochem; 2003 May; 247(1-2):121-6. PubMed ID: 12841639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge and nature of technetium species produced in the reduction of pertechnetate by stannous ion.
    Owunwanne A; Marinsky J; Blau M
    J Nucl Med; 1977 Nov; 18(11):1099-105. PubMed ID: 915087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation and control of pyrrolidino-methyl tetracycline labelled with 99mTc.
    Zmbova B; Zivanov-Stakić D; Tadzer I; Bogdanova V
    Int J Appl Radiat Isot; 1978 Jun; 29(6):359-62. PubMed ID: 750498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.